Formulation and evaluation_of_microspheres[1]

45
FORMULATION AND EVALUATION OF MICROSPHERES PRESENTED BY DADHICHI K THAKKAR M.PHARM SEMISTER -I

description

 

Transcript of Formulation and evaluation_of_microspheres[1]

Page 1: Formulation and evaluation_of_microspheres[1]

FORMULATION AND EVALUATION OFMICROSPHERES

PRESENTED BY

DADHICHI K THAKKAR M.PHARM SEMISTER -I Guided by :-Dr UPENDRA PATEL DEPARTMENT OF PHARMACUETICAL TECHNOLOGY

ARIHANT COLLEGE OF PHARMACYGUJARAT TECHNICAL UNIVERSITY..

Page 2: Formulation and evaluation_of_microspheres[1]

CONTENTS

INTRODUCTION CLASSIFICATION OF POLYMERS. METHODS OF PREPARATION. CHARACTERIZATION. APPLICATIONS. CONCLUSION. REFERENCES

Page 3: Formulation and evaluation_of_microspheres[1]

INTRODUCTION• The oral route is considered as the most promising

route of drug delivery. Conventional drug delivery system achieves as well as maintains the drug concentration within the therapeutically effective range needed for treatment, only when taken several times a day.

• This results in a significant fluctuation in drug levels. A well defined controlled drug delivery system can overcome some of the problems of conventional therapy and enhance the therapeutic efficacy of a given drug..

• There are various approaches in delivering a therapeutic susbstance to the target site in sustained controlled release fashion using microspheres as carrier for drug

Page 4: Formulation and evaluation_of_microspheres[1]

• Administration of drugs in the form of microspheres usually improves the treatment by providing the localization of the active substances at the site of action & by prolonging the release of drugs.

Contd.,

Page 5: Formulation and evaluation_of_microspheres[1]

Definition of microspheres

• Microparticles or microspheres are defined as small, insoluble, free flowing spherical particles consisting of a polymer matrix and drug. and sized from about 50 nm to about 2 mm.

• The term nanospheres is often applied to the smaller spheres (sized 10 to 500 nm) to distinguish them from larger microspheres

Page 6: Formulation and evaluation_of_microspheres[1]

• Ideally, microspheres are completely spherical and homogeneous in size

Page 7: Formulation and evaluation_of_microspheres[1]

• Microspheres are made from polymeric , waxy or protective materials that is biodegradable synthetic polymers and modified natural products.

• Microspheres are manufactured in both solid and hollow form. Hollow microspheres are used as additives to lower the density of a material.

• Solid biodegradable microspheres incorporating a drug dispersed or dissolved throughout particle matrix have the potential for controlled release of the drug.

• These carriers received much attention not only for prolonged release but also for the targeting anti cancer drugs to the tumour.

Page 8: Formulation and evaluation_of_microspheres[1]

Advantages

• Controlled release for longer period of time (like 1-3 months).

• Frequency is reduced and hence patient compliance is increased.

• Constant release and hence no peaks and troughs in concentration of drug.

• Low dose and hence toxic effect is less.• Targeting the tissue is possible.• Other organ toxicity is less.• No distribution through out the body (no dilution

effect)

Page 9: Formulation and evaluation_of_microspheres[1]

Disadvantages

• Intended mainly for parenteral route which causes pain.

• Forms a depot in tissue or muscle for longer period and hence may produce pain when muscle activities are done.

• Once administered, it is difficult to take back the dose.

• Polymer may produce toxic effects.• High cost.

Page 10: Formulation and evaluation_of_microspheres[1]

Potential use of microspheres in the pharmaceutical industry

• Taste and odor masking.• Conversion of oils and other liquids to solids for ease of

handling.• Protection of drugs against the environment (moisture,

light etc.).• Separation of incompatible materials (other drugs or

excipients).• Improvement of flow of powders.• Aid in dispersion of water-insoluble substances in

aqueous media, and Production of SR, CR, and targeted medications.

Page 11: Formulation and evaluation_of_microspheres[1]

Polymers used in the Microsphere preparation

Synthetic Polymers Non-biodegradable • PMMA • Acrolein• Epoxy polymers

Biodegradable• Lactides and Glycolides copolymers• Polyalkyl cyanoacrylates• Polyanhydrides

Page 12: Formulation and evaluation_of_microspheres[1]

• Natural Materials Proteins• Albumins• Gelatin• Collagen Carbohydrates• Starch agarose• Carrageenan• Chitosan Chemically modified carbohydrates• Poly(acryl)dextran• Poly(acryl)starch

Page 13: Formulation and evaluation_of_microspheres[1]

Prerequisites for Ideal Microparticulate Carriers

Longer duration of action Control of content release Increase of therapeutic efficacy Protection of drug Reduction of toxicity Biocompatibility Sterilizability Relative stability Water solubility or dispersibility Bioresorbability Targetability Polyvalent

Page 14: Formulation and evaluation_of_microspheres[1]

Types of Microspheres

• Microcapsule: consisting of an encapsulated core particle. Entrapped substance completely surrounded by a distinct capsule wall.

• Micromatrix: Consisting of homogenous dispersion of active ingredient in particle.

Microcapsule Micromatrix

Types of Microspheres

Page 15: Formulation and evaluation_of_microspheres[1]

MICROSPHERE MANUFACTURE

• Most important physicochemical characteristics that may be controlled in microsphere manufacture are:

Particle size and distribution Polymer molecular weight Ratio of drug to polymer Total mass of drug and polymer

Page 16: Formulation and evaluation_of_microspheres[1]

GENERAL METHODS OF PREPARATION

• Single Emulsion techniques• Double emulsion techniques• Polymerization techniques - Normal polymerization. - Interfacial polymerization• Coacervation phase separation techniques• Emulsification-solvent evaporation method• Spray drying and spray congealing• Brace process

Page 17: Formulation and evaluation_of_microspheres[1]

SINGLE EMULSION BASED METHOD

Aq.Solution/suspension of polymer

Dispersion in organic phase (Oil/Chloroform)

Microspheres in organic phase Microspheres in organic phase

MICROSPHERES

Stirring, Sonication

CROSS LINKING

Chemical cross linking (Glutaraldehyde/Formaldehyde/ButanolHeat denaturation

Centrifugation, Washing, Separation

Page 18: Formulation and evaluation_of_microspheres[1]

Aq.Solution of protein/polymer

First emulsion (W/O)

MICROSPHERES

Dispersion in oil/organic phaseHomogenization

Separation, Washing, Drying

Addition of aq. Solution of PVA

Addition to large aq. PhaseDenaturation/hardening

Multiple emulsion

Microspheres in solution

DOUBLE EMULSION BASED METHOD

Page 19: Formulation and evaluation_of_microspheres[1]

Interfacial Polymerization technique

• When two reactive monomers are dissolved in immiscible solvents, the monomers diffuse to the oil- water interface where they react to form a polymeric membrane that envelopes dispersed phase.

• Drug is incorporated either by being dissolved in the polymerization medium or by adsorption onto the nanoparticles after polymerization completed.

• The nanoparticle suspension is then purified to remove various stabilizers and surfactants employed for polymerization by ultracentrifugation and re- suspending the particles in an isotonic surfactant-free medium.

Page 20: Formulation and evaluation_of_microspheres[1]
Page 21: Formulation and evaluation_of_microspheres[1]

PHASE SEPARATION METHOD

Aqueous/Organic.Solution of polymer

Drug dispersed or dissolved in polymer solution

MICROSPHERES

Drug

Separation, Washing, Drying

Hardening

Polymer rich globules

Microspheres in aq./organic phase

Page 22: Formulation and evaluation_of_microspheres[1]

Salting-out process

• An aqueous phase saturated with electrolytes (e.g., magnesium acetate, magnesium chloride) and containing PVA as a stabilizing and viscosity increasing agent is added under vigorous stirring to an acetone solution of polymer.

• In this system, the miscibility of both phases is prevented by the saturation of the aqueous phase with electrolytes, according to a salting-out phenomenon.

• The addition of the aqueous phase is continued until a phase inversion occurs and an o/w emulsion is formed

Page 23: Formulation and evaluation_of_microspheres[1]

Emulsification-Solvent

evaporation method

Page 24: Formulation and evaluation_of_microspheres[1]

Spray drying and spray congealing method• These methods are based on drying of the mist of polymer

and drug in air. Depending on the removal of solvent or cooling the solution are named as “drying” and “congealing”, respectively.

• The polymer dissolved in a suitable volatile organic solvent (dichloromethane,acetone,etc)

• The drug in the solid form is then dissolved in polymer solution under high speed homogenization.

• This dispersion is atomized in a stream of hot air.• This leads to formation of small droplets from which

solvent evaporates leading to the formation of microspheres.

• These are then separated from hot air by means of cyclone separator.

• Spray congealing involves the formation of microspheres by solidifying the melted mass of drug and polymer in the form of minute particles.

Page 25: Formulation and evaluation_of_microspheres[1]

Ultra Spherical Microspheres

Microspheres with a monodisperse grain size distribution and the smallest divergence are manufactured by BRACE.

• perfectly spherical Microspheres

• monodisperse grain size, narrow size distribution with diameters between 50µm and 5000µm

• nonabrading, therefore dust-free

• free flowing, porous, large surface area,soft or rigid

The BRACE-Process

Page 26: Formulation and evaluation_of_microspheres[1]

The BRACE-Process A liquid is gently pumped through a vibrating nozzle

system whereupon exiting the fluid stream breaks up into uniform droplets.

The surface tension of these droplets moulds them into perfect spheres in which gelation is induced during a short period of free fall.

Solidification can be induced in a gaseous and/or liquid medium through cooling, drying, or chemical reaction.

There are no constraints on the type of liquid—molten materials, solutions, dispersions, sols, or suspensions can be used to manufacture perfectly spherical Microspheres.

Page 27: Formulation and evaluation_of_microspheres[1]
Page 28: Formulation and evaluation_of_microspheres[1]

DRUG LOADING

• During the preparation of microspheres or after the formation of microspheres by incubating.

• Loading into preformed microspheres has an advantage of removing all impurities from microsphere preparation before the drug is incorporated.

• High loading can be achieved by insitu loading.

Page 29: Formulation and evaluation_of_microspheres[1]

ROUTE OF ADMINISTRATION

ORAL DELIVERY

PARENTERAL DELIVERY

Page 30: Formulation and evaluation_of_microspheres[1]

CHARACTERIZATION

PARTICLE SIZE.

PARTICLE SHAPE.

DENSITY DETERMINATION.

ISOELECTRIC POINT.

CAPTURE EFFICIENCY.

RELEASE STUDIES.

ANGLE OF CONTACT.

Page 31: Formulation and evaluation_of_microspheres[1]

PARTICLE SIZE AND SHAPE

• Particle size and distribution can be determined by

conventional light microscopy scanning electron microscopyConfocal laser scanning microscopyConfocal fluorescence microscopyLaser light scattering and multisize coulter counter

Page 32: Formulation and evaluation_of_microspheres[1]

PARTICLE SIZE

Page 33: Formulation and evaluation_of_microspheres[1]

PARTICLE SHAPE

Page 34: Formulation and evaluation_of_microspheres[1]

DENSITY DETERMINATIONMeasured by using a Multivolume

psychnometer.

ISOELECTRIC POINTThe microelectrophoresis is an apparatus

used to measure the electophoretic mobility of microspheres from which isoelectric point can be determined.

Page 35: Formulation and evaluation_of_microspheres[1]

CAPTURE EFFICIENCY

Page 36: Formulation and evaluation_of_microspheres[1]

RELEASE STUDIES

• Rotating paddle apparatus

• Dialysis method

ANGLE OF CONTACT

Determine wetting property of microparticulate carrier.

Page 37: Formulation and evaluation_of_microspheres[1]

APPLICATIONS MICROSPHERES IN VACCINE DELIVERY.

Eg ; Diphtheria toxoid , Tetanus toxoid.

TARGETED DRUG DELIVERY. Eg ; ocular, eye (cornea).etc

CONTROLLED RELEASE. Eg ; luprodine (prostate cancer).

CHEMOEMBOLIZATION.

Gene delivery

Page 38: Formulation and evaluation_of_microspheres[1]

OTHER APPLICATIONS• Microcapsules are also extensively used as diagnostics, for

example, temperature-sensitive microcapsules for thermographic detection of tumors.

• In the biotechnology industry microencapsulated microbial cells are being used for the production of recombinant proteins and peptides.

• Encapsulation of microbial cells can also increase the cell-loading capacity and the rate of production in bioreactors.

• A feline breast tumor line, which was difficult to grow in conventional culture, has been successfully grown in microcapsules.

• Microencapsulated activated charcoal has been used for hemoperfusion.

Page 39: Formulation and evaluation_of_microspheres[1]

• Modified release microspheres of indomethacin were prepared by the emulsion solvent diffusion technique using a synthetic polymer, Acrycoat s100.

• Microspheres of diltiazem hydrochloride were formulated using combination of polyethylene glycol 6000 and Eudragit RS 100 and Eudragit RS 100 alone by solvent evaporation and non-solvent addition methods with an aim to prolong its release

Page 40: Formulation and evaluation_of_microspheres[1]

Cancer research

• One useful discovery made from the research of microspheres is a way to fight cancer on a molecular level. According to Wake Oncologists, "SIR-Spheres microspheres are radioactive polymer spheres that emit beta radiation. Physicians insert a catheter through the groin into the hepatic artery and deliver millions of microspheres directly to the tumor site. The SIR-Spheres microspheres target the liver tumors and spare healthy liver tissue. Approximately 55 physicians in the United States use Sirtex’s SIR-Spheres microspheres in more than 60 medical centers.

Page 41: Formulation and evaluation_of_microspheres[1]

CONCLUSION The concept of microsphere drug delivery systems

offers certain advantages over the conventional drug delivery systems such as controlled and sustained delivery. Apart from that microspheres also allow drug targeting to various systems such as ocular , intranasal , oral and IV route .

Novel technologies like magnetic microspheres, immunomicrospheres offer great advantages and uses than conventional technologies.

Page 42: Formulation and evaluation_of_microspheres[1]

Further more in future by combining various other strategies, microspheres will find the central place in novel drug delivery, particularly in diseased cellsorting ,diagnostics, gene and genetic materials, safe,targated and effective invivo delivery which may have implications in gene therapy.

This area of novel drug delivery has innumerable applications and there is a need for more research to be done in this area.

Page 43: Formulation and evaluation_of_microspheres[1]

REFERENCES S.P.Vyas., R.K.Khar, International Journal for

Targeted & Controlled Drug Delivery Novel Carrier Systems.,

First Edition :2002.,Reprint :2007 page no:417,453.

Review: Radioactive Microspheres for Medical Applications.

International journal of Pharmaceutics 282 (2004) 1-18,Review polymer microspheres for controlled drug release.

N.K.Jain ,Controlled and novel drug delivery edited by reprint 2007 pg.no.236-255.

Page 44: Formulation and evaluation_of_microspheres[1]

Donald L.Wise, Handbook of pharmaceutical controlled release technology.

James Swarbrick, James C.Boylan ,Encyclopedia of pharmaceutical technology Editors, volume-10.

Patrick B.Deasy, Microencapsulation and related drug delivery processes edited by.

James Swarbrick, Encyclopedia of pharmaceutical technology , 3rd edition volume-4 .

www.koboproducts.com www.brace.com www.wikipedia.org [email protected] www.harperintl.com. www.pharmacy2011foru.blogspot.com

Page 45: Formulation and evaluation_of_microspheres[1]

THANK YOU